Senior Director Business Unit Switzerland and Austria @ (March 2017 - January 2021)
General Manager and Managing Director Switzerland and Austria @
Managing Partner @ Audax & Socius International Pharma Consulting (June 2016 - Present)
Global Associated Brand Director @ (July 2013 - October 2013)
Head Specialty and Oncology Africa Cluster @ (September 2010 - June 2013)
Head Marketing Science Region Europe @ (February 2009 - August 2010)
Member of the Board of Directors @ (June 2009 - Present)
Head Sales Ophthalmology Otc @ (January 2008 - January 2009)
Product Manager Respiratory Franchise @ (January 2006 - January 2009)
Head Sales Force Effectiveness @ (January 2003 - December 2005)
Project Officer Direct Business @ (February 2000 - December 2002)
Oliver K Education
Université de Fribourg - Universität Freiburg
Doctor of Philosophy (Marketing, Management, Philosophy)
2001
Université de Fribourg - Universität Freiburg
Master of Business Administration (Marketing, Management)
1996
Monta Vista High School, Cupertino, Ca, Usa 1988
Oliver K Skills
Swiss German
German
French
Spanish
English
Portuguese
Italian
Marketing
Sales
Leadership
Emerging Markets
Market Analysis
Pharmaceutical Industry
Pharmaceutical Sales
Sales Effectiveness
Oncology
Strategy
Global Marketing
Product Launch
Cross-functional Team Leadership
Dermatology
Biotechnology
Market Access
International Marketing
Oliver K Summary
Oliver K, based in Zürich, ZH, CH, is currently a Managing Partner at AUDAX & Socius - International Pharma Consulting. Oliver K brings experience from previous roles at Selectchemie Ag, Otsuka Pharmaceutical Companies Europe, Stallergenes Greer and Audax & Socius International Pharma Consulting. Oliver K holds a Doctor of Philosophy in Marketing, Management, Philosophy @ Université de Fribourg - Universität Freiburg. With a robust skill set that includes Swiss German, German, French, Spanish, English and more. Oliver K has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Oliver K?
Find contact details for 700 million professionals.